Pitofsky Jason — SEC insider filings
SEC reporting owner CIK 2009236. 7 insider filings on record with FilingPulse; latest filed 2026-11-06.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-08-07 to 2026-11-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 21 legs across 4 filings — 7,016 shares, $6,214,074 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: sale of 1,215 shares @ $942.31 ($1,144,907) in REGENERON PHARMACEUTICALS, INC., filed 2026-11-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. (REGN) | SVP Controller | 7 | — | 21 legs · 7,016 sh · $6,214,074 | 19 |
Insider filings — Pitofsky Jason
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-06 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,500 @ $726.53 · Option exercise (M): 1,478 @ $644.54 · Option exercise (M): 905 @ $492 · Sale (S): 439 @ $939.57 · Sale (S): 575 @ $940.46 · Sale (S): 982 @ $941.58 · +8 more | EDGAR |
| 2026-02-11 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,000 @ $492 · Sale (S): 20 @ $775.95 · Sale (S): 521 @ $776.43 · Sale (S): 391 @ $777.51 · Sale (S): 563 @ $778.35 · Sale (S): 205 @ $779.56 · +7 more | EDGAR |
| 2025-12-09 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 2,064 @ $0 · Tax withholding (F): 989 @ $712.94 · Grant/award (A): 2,261 (derivative) @ $0 | EDGAR |
| 2025-11-10 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 431 @ $651.43 | EDGAR |
| 2024-12-18 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax withholding (F): 298 @ $730.81 | EDGAR |
| 2024-12-10 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 907 @ $0 · Tax withholding (F): 149 @ $787 · Gift (G): 89 @ $0 · Gift (G): 90 @ $0 · Grant/award (A): 3,236 (derivative) @ $0 | EDGAR |
| 2024-08-07 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 487 @ $372.46 · Sale (S): 487 @ $1,070 · Option exercise (M): 487 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-03-15 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2009236 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs